ArticleArchives of medical science : AMS2026
Serum 25-hydroxyvitamin D levels and
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The association between serum 25-hydroxyvitamin D levels and Material and methods: In this real-world observational study, a total of 1898 participants, including 103 patients with CDE and 1795 non-CDE controls, were selected from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Logistic regression and restricted cubic spline (RCS) analyses were used to evaluate the association between serum 25-hydroxyvitamin D levels and the risk of CDE. To assess the potential causal relationship between the two factors, two-sample Mendelian randomization (MR) analysis was performed. Results: After adjustments were made for multiple confounders, a high serum 25-hydroxyvitamin D level (odds ratio [OR] = 0.9764; 95% confidence interval [CI], 0.9585-0.9932; Conclusions: This study suggests that low serum 25-hydroxyvitamin D levels are associated with an increased risk of CDE, and this relationship is potentially causal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.